Get the Stockscreener App
4.20
8.70%
-0.40
Vivos Therapeutics Inc stock is traded at $4.20, with a volume of 163.27K.
It is down -8.70% in the last 24 hours and down -23.64% over the past month.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
See More
Previous Close:
$4.60
Open:
$4.49
24h Volume:
163.27K
Relative Volume:
0.23
Market Cap:
$24.74M
Revenue:
$14.58M
Net Income/Loss:
$-12.57M
P/E Ratio:
-0.7394
EPS:
-5.68
Net Cash Flow:
$-13.07M
1W Performance:
+2.19%
1M Performance:
-23.64%
6M Performance:
+34.62%
1Y Performance:
+55.57%
1-Day Range:
$4.1622
$4.495
1-Week Range:
$3.54
$4.60
52-Week Range:
$1.98
$7.95
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Name
Vivos Therapeutics Inc
Sector
Industry
Phone
(866)908-4867
Address
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
4.20 | 26.21M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Vivos Therapeutics Inc Stock (VVOS) Latest News
Vivos Therapeutics' Strategic Pivot: Can the Sleep Optimization Model Redefine OSA Treatment Leadership? - AInvest
Vivos Reports 7% Sales Drop - The Motley Fool
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update - TradingView
Vivos Therapeutics Q2 FY25: Revenue up 25%, Acquires Sleep Center of Nevada - AInvest
Vivos Therapeutics Inc. Stock Approaches Key Moving Average2025 Macro Impact & AI Based Trade Execution Alerts - newsyoung.net
Biotech Sector Resilience and Vivos Therapeutics: A High-Risk, High-Reward Proposition? - AInvest
Vivos Therapeutics Announces Q2 2025 Financial Results Release and Conference Call - AInvest
Vivos Therapeutics Reports Q2 2025 Earnings: Revenue Challenges and Strategic Growth - AInvest
Market reaction to Vivos Therapeutics Inc.’s recent newsMarket Risk Analysis & Reliable Price Action Trade Plans - Newser
Recovery Signals Appearing in Vivos Therapeutics Inc. Charts2025 Stock Rankings & Stepwise Trade Signal Guides - beatles.ru
What the charts say about Vivos Therapeutics Inc. today2025 Biggest Moves & Free Reliable Trade Execution Plans - Newser
Visualizing Vivos Therapeutics Inc. stock with heatmaps2025 Historical Comparison & Accurate Intraday Trade Tips - Newser
Vivos Therapeutics Unveils New Model - AOL.com
Custom strategy builders for tracking Vivos Therapeutics Inc.Market Activity Summary & Expert Verified Stock Movement Alerts - Newser
Vivos Therapeutics Shifts Strategy Amid Financial Challenges - TipRanks
What candlestick patterns are forming on Vivos Therapeutics Inc.Market Growth Report & Stepwise Entry/Exit Trade Alerts - Newser
What to expect from Vivos Therapeutics Inc. in the next 30 days2025 AllTime Highs & Growth Focused Entry Reports - Newser
Transcript : Vivos Therapeutics, Inc., Q2 2025 Earnings Call, Aug 19, 2025 - MarketScreener
Vivos Therapeutics Shifts to Direct Sleep Center Model, Posts $3.8M Q2 Revenue, and Raises $11.5M in New Capital. - AInvest
Using fundamentals and technicals on Vivos Therapeutics Inc.2025 Bull vs Bear & Reliable Price Breakout Signals - Newser
Earnings call transcript: Vivos Therapeutics reports Q2 2025 earnings miss - Investing.com
Vivos Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Vivos Therapeutics Q2 2025 Financial Results: Revenue Down Due to Strategic Pivot, New Model Shows Promise - AInvest
$500K Revenue in Just 20 Days: Vivos' New Sleep Center Acquisition Shows Strong Early Results in Q2 2025 - Stock Titan
Vivos Therapeutics, Inc. SEC 10-Q Report - TradingView
Reversal indicators forming on Vivos Therapeutics Inc. stockQuarterly Performance Summary & Risk Controlled Stock Pick Alerts - Newser
Is Vivos Therapeutics Inc. stock bottoming out2025 Pullback Review & AI Forecasted Entry/Exit Points - Newser
Earnings visualization tools for Vivos Therapeutics Inc.Weekly Trade Recap & Risk Controlled Swing Alerts - Newser
News impact scoring models applied to Vivos Therapeutics Inc.Bear Alert & Safe Entry Point Identification - Newser
Vivos Therapeutics, Inc. Announces Upcoming Release of Second Quarter 2025 Financial Results and Conference Call - Quiver Quantitative
Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call - The Manila Times
Sleep Apnea Treatment Innovator Vivos Therapeutics Sets Q2 2025 Earnings Call for August 19 - Stock Titan
Published on: 2025-08-19 05:12:42 - Newser
Can Vivos Therapeutics Inc. hit a new high this monthJuly 2025 Spike Watch & Low Volatility Stock Recommendations - Newser
Should you hold or exit Vivos Therapeutics Inc. nowWeekly Stock Recap & High Yield Equity Trading Tips - Newser
Tick level data insight on Vivos Therapeutics Inc. volatilityJuly 2025 Movers & Real-Time Volume Analysis Alerts - Newser
Vivos Therapeutics Inc. stock trend forecastJuly 2025 Retail & Weekly High Return Stock Opportunities - Newser
What data driven models say about Vivos Therapeutics Inc.’s futureWeekly Profit Recap & AI Optimized Trade Strategies - Newser
AI Trend Models Suggest Bounce for Vivos Therapeutics Inc.Bond Market & Accurate Intraday Trading Signals - newsimpact.co.kr
Is Vivos Therapeutics Inc. meeting your algorithmic filter criteriaVolume Spike & Advanced Technical Signal Analysis - Newser
Detecting price anomalies in Vivos Therapeutics Inc. with AIWeekly Market Report & Expert Curated Trade Setup Alerts - Newser
Quantitative breakdown of Vivos Therapeutics Inc. recent moveEarnings Risk Report & Technical Confirmation Alerts - Newser
Published on: 2025-08-16 03:05:14 - Newser
How Interest Rate Changes Impact Vivos Therapeutics Inc. Stock PerformanceQuarterly Risk Review & Safe Capital Growth Trade Ideas - Newser
Vivos Therapeutics Inc Stock (VVOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):